Strides Arcolab’s subsidiary Agila Biotech (Malaysia) has signed a build-and-lease agreement with Bio X-cell worth RM107 million, in order to establish a customized biotech facility located in the Bio X-cell ecosystem in Nusajaya, Johar, Malaysia. Bio X-cell will fund RM67.32 million approximately to be provided under the build and lease agreement for construction of the building and part of the equipments. All other equipments and integration service and testing of this project will be funded by Agila Biotech.
The work on the project is expected to start after all necessary clearances and permits have been obtained and all supplemented agreements have been executed. The R&D and manufacturing facilities is expected to be operational by end of 2014.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: